patrick.net

modRNA technology has been a failure in health care. It may never have a place in health care, only medical care for seriously ill patients. Nature has the answers. modRNA is anti-nature, anti-God. Vitamin D, vitamin C, zinc, colloidal silver etc should replace all vaccines.
Study Reveals COVID-19 'Vaccines' Have Far Exceeded Criteria for Market Withdrawal modRNA技术在医疗保健领域一直失败。 它可能永远不会在医疗保健领域占有一席之地，而只会在重病患者的医疗保健领域占有一席之地。 大自然有答案。 modRNA是反自然、反上帝的。 维生素D、维生素C、锌、胶体银等应取代所有疫苗。

研究显示 COVID-19“疫苗”远远超过了退出市场的标准

https://open.substack.com/pub/petermcculloughmd/p/study-reveals-covid-19-vaccines-have

Ian Brighthope's Substack cross-posted a post from Courageous Discourse™ with Dr. Peter McCullough & John Leake

Ian Brighthope
Dec 29 · Ian Brighthope's Substack
modRNA technology has been a failure in health care. It may never have a place in health care, only medical care for seriously ill patients. Nature has the answers. modRNA is anti-nature, anti-God. Vitamin D, vitamin C, zinc, colloidal silver etc should replace all vaccines.

Study Reveals COVID-19 'Vaccines' Have Far Exceeded Criteria for Market Withdrawal
375,340% more reported deaths than the Cutter Polio Vaccine Incident of 1955.
NICOLAS HULSCHER, MPH
DEC 29

READ IN APP

by Nicolas Hulscher, MPH

Last month, the study titled Pharmaceutical product recall and educated hesitancy towards new drugs and novel vaccines, was published in the International Journal of Risk & Safety in Medicine. Here’s a brief summary as presented in the Abstract:

Background: Of many pharmaceutical products launched for the benefit of humanity, a significant number have had to be recalled from the marketplace due to adverse events. A systematic review found market recalls for 462 pharmaceutical products between 1953 and 2013. In our current and remarkable period of medical history, excess mortality figures are high in many countries. Yet these statistics receive limited attention, often ignored or dismissed by mainstream news outlets. This excess mortality may include adverse effects caused by novel pharmaceutical agents that use gene-code technology.

Objective: To examine key pharmaceutical product withdrawals and derive lessons that inform the current use of gene-based COVID-19 vaccines.

Methods: Selective narrative review of historical pharmaceutical recalls and comparative issues with recent COVID-19 vaccines.

Results: Parallels with past drug withdrawals and gene-based vaccines include distortion of clinical trial data, with critical adverse event data absent from high-impact journal publications. Delayed regulatory action on pharmacovigilance data to trigger market withdrawal occurred with Vioxx (rofecoxib) and is apparent with the gene-based COVID-19 vaccines.

Conclusion: Public health requires access to raw clinical trial data, improved transparency from corporations and heightened, active pharmacovigilance worldwide.

Figure 1 reveals the shockingly high number of COVID-19 injection death reports compared to all other vaccines since 1990. The fact that our regulatory authorities ignore this absurdly strong safety signal is deeply worrisome:

Figure 3 presents a table in Edward Dowd’s book Cause Unknown, showing a strong temporal correlation between the onset of USA COVID-19 vaccine mandates for employment in the third quarter of 2021 and a significant rise in excess mortality among working-age Americans (25–64 years old), based on data collated by the US Society of Actuaries Research Institute:

Figure 4 illustrates the striking comparison of reported deaths for major drug/vaccine recalls versus COVID-19 injection deaths. As you can see, COVID-19 ‘vaccines’ are LONG overdue for market recall, with 375,340% more reported deaths than the disastrous Cutter Polio Vaccine Incident of 1955, which led to immediate market withdrawal after only 10 deaths:

In support of these findings, our study, A Systematic Review Of Autopsy Findings In Deaths After COVID-19 Vaccination, has demonstrated a causal link between COVID-19 ‘vaccines’ and death:

Immediate action to remove these deadly injections from the market should be a top priority for the incoming administration. Failure to do so would likely cause an irreversible loss of trust in our government and represent a grave disservice to the American people, the majority of whom are refusing COVID-19 genetic booster shots with no human data.

Nicolas Hulscher, MPH

Epidemiologist and Foundation Administrator, McCullough Foundation

www.mcculloughfnd.org

Please consider following the McCullough Foundation and Nicolas Hulscher on X (formerly Twitter) for further content.

Upgrade to paid

LIKE
COMMENT
RESTACK

Originally posted on
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Courageous Discourse™ with Dr. Peter McCullough & John Leake
Peter A. McCullough, MD, MPH
Subscribe
Advancement of clinical science, protection of personal autonomy, liberty, and constitutional rights. Ian Brighthope 的 Substack 与 Peter McCullough 博士和 John Leake 交叉发布了 Courageous Discourse™ 的帖子

伊恩·布莱霍普
12 月 29 日 · Ian Brighthope 的子堆栈
modRNA技术在医疗保健领域一直失败。 它可能永远不会在医疗保健领域占有一席之地，而只会在重病患者的医疗保健领域占有一席之地。 大自然有答案。 modRNA是反自然、反上帝的。 维生素D、维生素C、锌、胶体银等应取代所有疫苗。

研究显示 COVID-19“疫苗”远远超过了退出市场的标准
报告的死亡人数比 1955 年卡特脊髓灰质炎疫苗事件多 375,340%。
尼古拉斯·胡尔舍，公共卫生硕士
12月29日

在应用程序中阅读

作者：Nicolas Hulscher，公共卫生硕士

上个月，这项题为“药品召回以及对新药和新型疫苗的教育犹豫”的研究发表在《国际医学风险与安全杂志》上。 以下是摘要中的简要总结：

背景：在为人类造福而推出的许多药品中，有相当一部分因不良事件而不得不从市场上召回。 一项系统审查发现，1953 年至 2013 年间，市场召回了 462 种药品。在我们当前这一非凡的医学历史时期，许多国家的超额死亡率都很高。 然而，这些统计数据受到的关注有限，常常被主流新闻媒体忽视或忽视。 这种过高的死亡率可能包括使用基因密码技术的新型药剂引起的不利影响。

目标：检查关键药品的撤回情况，并吸取经验教训，为当前基于基因的 COVID-19 疫苗的使用提供信息。

方法：对历史药物召回以及与最近的 COVID-19 疫苗的比较问题进行选择性叙述回顾。

结果：与过去的药物撤回和基于基因的疫苗的相似之处包括临床试验数据的扭曲，高影响力期刊出版物中缺乏关键的不良事件数据。 Vioxx（罗非昔布）因延迟对药物警戒数据采取监管行动而导致市场退出，这一点在基于基因的 COVID-19 疫苗中尤为明显。

结论：公共卫生需要获取原始临床试验数据、提高企业透明度以及在全球范围内加强、积极的药物警戒。

图 1 显示了自 1990 年以来，与所有其他疫苗相比，COVID-19 注射死亡报告的数量高得惊人。我们的监管机构忽视了这一异常强烈的安全信号，这一事实令人深感担忧：

图 3 显示了 Edward Dowd 所著《原因未知》中的表格，显示了美国 2021 年第三季度开始实施新冠肺炎 (COVID-19) 疫苗强制就业与美国劳动年龄人口 (25-25 岁) 超额死亡率显着上升之间存在很强的时间相关性。 64岁），根据美国精算师协会研究所整理的数据：

图 4 展示了主要药物/疫苗召回导致的死亡报告与 COVID-19 注射死亡的惊人比较。 正如您所看到的，COVID-19“疫苗”早就该召回市场了，报告的死亡人数比 1955 年灾难性的 Cutter 脊髓灰质炎疫苗事件多了 375,340%，该事件导致仅 10 人死亡后立即撤回市场：

为了支持这些发现，我们的研究《对 COVID-19 疫苗接种后死亡的尸检结果进行系统审查》证明了 COVID-19“疫苗”与死亡之间的因果关系：

立即采取行动，将这些致命注射剂从市场上撤下，应该是即将上任的政府的首要任务。 如果不这样做，可能会导致对我们政府的信任不可逆转地丧失，并对美国人民造成严重伤害，他们中的大多数人在没有人体数据的情况下拒绝接受 COVID-19 基因加强注射。

尼古拉斯·哈尔舍，公共卫生硕士

麦卡洛基金会流行病学家兼基金会管理员

www.mcculloughfnd.org

请考虑在 X（以前称为 Twitter）上关注 McCullough 基金会和 Nicolas Hulscher 以获取更多内容。

升级至付费

喜欢
评论
重新堆叠

最初发布于
Peter McCullough 博士和 John Leake 的 Courageous Discourse™
Peter McCullough 博士和 John Leake 的 Courageous Discourse™
Peter A. McCullough，医学博士、公共卫生硕士
订阅
临床科学的进步，保护个人自主权、自由和宪法权利。